Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants
O Egbuna, B Zimmerman, G Manos… - … England Journal of …, 2023 - Mass Medical Soc
Background Persons with toxic gain-of-function variants in the gene encoding
apolipoprotein L1 (APOL1) are at greater risk for the development of rapidly progressive …
apolipoprotein L1 (APOL1) are at greater risk for the development of rapidly progressive …
[引用][C] Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants
MJ Soler, RJ Glassock… - New England …, 2023 - mayoclinic.elsevierpure.com
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants — Mayo Clinic
Skip to main navigation Skip to search Skip to main content Mayo Clinic Home Mayo Clinic …
Skip to main navigation Skip to search Skip to main content Mayo Clinic Home Mayo Clinic …
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants
O Egbuna, B Zimmerman, G Manos… - The New England …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Persons with toxic gain-of-function variants in the gene encoding
apolipoprotein L1 (APOL1) are at greater risk for the development of rapidly progressive …
apolipoprotein L1 (APOL1) are at greater risk for the development of rapidly progressive …
[PDF][PDF] Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants
O Egbuna, B Zimmerman, G Manos, A Fortier, KB MD… - sfndt.org
Les variants G1 et G2 du gène APOL1 confèrent une résistance à la trypanosomiase
africaine (Trypanosoma brucei rhodesiense, responsable de la maladie du sommeil) et sont …
africaine (Trypanosoma brucei rhodesiense, responsable de la maladie du sommeil) et sont …
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants.
O Egbuna, B Zimmerman, G Manos… - The New England …, 2023 - europepmc.org
Background Persons with toxic gain-of-function variants in the gene encoding
apolipoprotein L1 (APOL1) are at greater risk for the development of rapidly progressive …
apolipoprotein L1 (APOL1) are at greater risk for the development of rapidly progressive …
[引用][C] Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. Reply
O Egbuna, GM Chertow - The New England journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
[PDF][PDF] Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants
O Egbuna, B Zimmerman, G Manos, A Fortier, KB MD… - sfndt.org
Les variants G1 et G2 du gène APOL1 confèrent une résistance à la trypanosomiase
africaine (Trypanosoma brucei rhodesiense, responsable de la maladie du sommeil) et sont …
africaine (Trypanosoma brucei rhodesiense, responsable de la maladie du sommeil) et sont …
[引用][C] Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. Reply.
O Egbuna, GM Chertow - The New England Journal of Medicine, 2023 - europepmc.org
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. Reply. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …